Hormone research

Horm Res · ISSN (print) 0301-0163 · 13 papers in corpus
review 2009
doi:10.1159/000191299 ·PMID:9267815

Apoptosis has recently been proposed to represent programmed cell death. Several investigations have revealed that uterine endometrium in mammals can be regulated by apoptosis. However, apoptosis may be less likely to occur in human eutopic…

article 2008
doi:10.1159/000181335 ·PMID:2533148

The skeletal effects of two therapies for endometriosis that produce hypo-oestrogenism in 23 premenopausal women have been studied. Eleven women received goserelin 3.6 mg monthly by subcutaneous implant and 12 women received danazol 600 mg …

article 2008
doi:10.1159/000181319 ·PMID:2533161

Luteinising hormone-releasing hormone (LHRH) analogues administered by a continuous release system produce a more complete and constant inhibition of the pituitary-ovarian axis than do multiple, daily intranasal insufflations or a once dail…

article 2008
doi:10.1159/000181320 ·PMID:2533142

Endometriosis is a disease of unknown aetiology, multiple presentations and an enigmatic course during a woman’s reproductive years. Clinical aspects of the diagnosis and the rationale for its treatment are discussed.

article 2008
doi:10.1159/000181324 ·PMID:2613199

Posters on endometriosis at the International Symposium on Endocrine Therapy are reviewed and discussed. Mechanisms of various treatments are discussed, with a note on the possible immunological basis of endometriosis.

review 2008
doi:10.1159/000182151 ·PMID:1818013

Menstrual problems including amenorrhea, oligomenorrhea, irregular cycles, abnormal uterine bleeding or dysmenorrhea represent 50% of adolescents' gynecologic complaints. Irregular and anovulatory cycles are common during the first postmena…

article 2008
doi:10.1159/000181323 ·PMID:2613198

The recent ability to diagnose asymptomatic endometriosis has produced dilemmas, particularly with respect to the need for treatment. The first placebo-controlled study of drug treatment in asymptomatic endometriosis shows that although spo…

article 2008
doi:10.1159/000181334 ·PMID:2533147

Plasma lipid risk markers for coronary heart disease (CHD) are influenced by sex steroid concentrations. Therapies that alter sex hormone levels have the potential to affect CHD risk. Zoladex had no effect on plasma lipids, but increased hi…

review 2002
doi:10.1159/000058374 ·PMID:12053085

Cytochrome P-450 aromatase (P450arom), the key enzyme for estrogen biosynthesis, is encoded by a single gene, namely the CYP19 gene, localized on 15q21.2. The human CYP19 gene spans about 123 kb with a coding region of 9 exons (about 30 kb,…

article 1999
doi:10.1159/000023429 ·PMID:10640897

This study was designed to examine the biological implications of progesterone receptor form A (PR-A) and B (PR-B) mRNA expressions in human ovarian endometriosis (ectopic endometrium). A high ratio of PR-B to PR-AB (PR-A+PR-B) mRNA express…

other 1989
doi:10.1159/000181321 ·PMID:2613197

Endometriosis is a gynaecological disorder with a poorly understood histogenesis. Morphological findings indicate that with respect to the type and degree of differentiation, and endocrine dependency, the endometrium and endometriosis are d…

article 1989
doi:10.1159/000181330 ·PMID:2515146

In a pilot study, chronic pelvic pain associated with endometriosis, dysmenorrhoea or menorrhagia has been treated for prolonged periods with low dose buserelin (daily) and medroxy-progesterone (monthly). The partial inhibition of ovarian f…

other 1989
doi:10.1159/000181322 ·PMID:2533143

In addition to surgery, several hormonal treatments are available for endometriosis. Although efficacious, drug treatment is limited by side effects. Recent work with LHRH analogues as a potential treatment for endometriosis has shown promi…